Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Mar. 31, 2021
Current Assets:
Cash and cash equivalents	$ 32,938,021	$ 118,341,471
Accounts receivable, net	39,621,340	8,993,920
Due from related parties	18,934	15,657
Inventories	34,960,878	15,866,918
Prepaid expenses	3,412,497	2,402,366
Total Current Assets	110,951,670	145,620,332
Equipment, net	25,695,773	21,553,226
Other Assets:
Deposits	17,217,487	1,833,429
Licensing agreements, net	16,667	41,667
Patents, net	5,772,897	6,019,567
Other intangible assets, net	143,052,686	2,220,958
Goodwill	90,870,094
Right of use assets - operating leases	2,935,322	2,090,162
TOTAL ASSETS	396,512,596	179,379,341
Current Liabilities:
Accounts payable	20,807,941	4,371,974
Factoring liability	3,131,676	1,842,188
Accrued liabilities	5,452,427	3,462,785
Inventory credit facility	194,810	1,091,098
Current portion of contingent consideration payable	10,755,000
Current portion of operating lease liability	867,133	663,784
Current portion of note payable related party	654,461	625,147
Insurance premium note payable	1,134,159	41,517
Total Current Liabilities	42,997,607	12,098,493
Long-term Liabilities:
Contingent consideration payable, net of current portion	529,810	589,892
Notes payable related part, net of current portion	531,396	865,771
Note payable		4,000,000
Operating lease liability, net of current portion	2,195,095	1,477,656
Total Liabilities	46,253,908	19,031,812
Shareholders’ Equity:
Series A Cumulative Perpetual Preferred Stock 8.75%, ($25.00 per share, $0.001 par value) 1,400,000 shares issued and outstanding as of September 30, 2021	1,400
Common stock, $0.001 par value, 200,000,000 shares authorized 113,583,016 and 93,099,067 shares issued and outstanding at September 30, 2021 and March 31, 2021, respectively	113,583	93,100
Additional paid-in capital	369,431,456	202,073,968
Accumulated deficit	(19,287,751)	(41,819,539)
Total Shareholders’ Equity	350,258,688	160,347,529
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 396,512,596	$ 179,379,341